🎤 Join us at BIONEER’s Integrated Symposium at ESCMID Global 2025 in Vienna! Want to hear real-world experiences with cutting-edge molecular diagnostics? Don’t miss this opportunity to explore how IRON-qPCR™ and ExiStation™ FA 96 are transforming infectious disease testing — through real clinical performance data shared by global experts. 📍 Hall 10 (IS34) 🗓️ Sunday, 13 April 2025 | 16:15 – 17:45 Learn from experts and clinical leaders from France, Korea, the Philippines, and more — sharing results from on-the-ground evaluations of HIV, HBV, HCV, MTB, MDR/pre-XDR-TB, Carbapenem-resistance screening, and respiratory virus detection. Let’s shape the future of diagnostics together. #BIONEER #ESCMID #Vienna #IntegratedSymposium #ExiStationFA96 #IRONqPCR #MolecularDiagnostics #HIV #HBV #HCV #TBDetection #AMR #RV #POC
소개
Since its founding in 1992 Bioneer Corporation has established market leadership in Korea for most of the products it manufactures. Bioneer has built its business by providing researchers with superior, high quality products at excellent value. Over the years, Bioneer has developed a broad range of unique products that provide total genomic research solutions for life sciences research including genomics, nucleic acid-based molecular diagnostics and gene therapy studies. Bioneer has extensive R&D experience in developing new drugs as well as the use of siRNA and drug delivery systems, and provides unrivalled service and support for such tools. For example, through the creation, development, and commercialization of the S. pombe deletion mutant library, Bioneer provides an innovative tool for improving the development of new drugs. The S. pombe library accurately predicts the toxicity of drug candidates for anti-cancer, Hyperlipidemia and also provides molecular level mechanism analysis of natural compound drugs. The company is headquartered in South Korea with an oligonucleotide manufacturing facility in the U.S., a regional office in China, and is supported by a network of distributors throughout the world. For more information, please visit www.bioneer.com.
- 업계
- 생명공학 연구
- 회사 규모
- 직원 501 - 1,000명
- 본사
- Daejeon
- 유형
- 상장기업
- 설립
- 1992
- 전문 분야
- siRNA, miRNA, Gene Synthesis, Protein Expression/Purification, PCR, qPCR, Molecular Diagnostics 및 DNA/RNA Prep
위치
Bioneer 직원
업데이트
-
Join BIONEER at ESCMID Global 2025 in Vienna! We’re excited to showcase next-generation molecular diagnostics at ESCMID Global. Visit us to explore our cutting-edge solutions and see how we’re shaping the future of infectious disease diagnostics! 📢 One of the highlights you don’t want to miss: IRON-qPCR™ RFIA Kit (CE-IVD Certified) According to the ECDC (2022), 26.9% of MDR-TB cases that underwent second-line drug susceptibility testing were classified as pre-XDR-TB. Early detection is key to preventing further resistance and ensuring effective treatment. IRON-qPCR™ RFIA Kit enables All-in-One PCR detection of MTB, MDR-TB, and pre-XDR-TB in just 40 minutes—from sample to result analysis. The IRON-qPCR™ platform also enables the rapid detection of respiratory viruses, antimicrobial resistance (CRE), STI 12 pathogens, and more. 📍 Visit our booth (E540, Hall B) from April 12 to 15 and connect with us! #BIONEER #ESCMID #Vienna #IRONqPCR #MolecularDiagnostic #POC #TBDetection #RV #AMR #CRE #STI
-
-
Bioneer님이 퍼감
Founder, CEO & Chairman, Bioneer Group | CEO at Bioneer | CEO at siRNAgen Therapeutics | CEO at RNApharm
I am excited to announce that Bioneer will be participating in the New Technology Presentations at JASIS 2024. Join us for our presentation! - Title: Technological Advances in Gene Synthesis: Focus on Long Gene Synthesis - Date & Time: September 5, 14:45-15:15 - Location: TKP Venue No.2 https://lnkd.in/df3dktZr We are delighted to share our latest innovations and explore how they can benefit your research and applications. See you there! #JASIS2024 #NewTechnologyPresentations #GeneSynthesis #Biotechnology #LongGeneSynthesis #Bioneer #TechPresentation #LifefScienceResearch
-
-
Bioneer님이 퍼감
Founder, CEO & Chairman, Bioneer Group | CEO at Bioneer | CEO at siRNAgen Therapeutics | CEO at RNApharm
Bioneer team and I will be at JASIS 2024 from September 4-6 at the Makuhari Messe in Japan, you can find us at booth 7A-501. We’ll be showcasing our innovations, including the #ExiPrep™ 96 Lite, a fully automated nucleic acid extraction system; the #ExiCycler™ V5, an automated PCR instrument with the world’s fastest ramping rate; and the #ExiProgen™, an advanced automated protein synthesis and purification system. We look forward to connecting with you there! #JASIS2024 #MakuhariMesse #KOREALAB #Bioneer #LifeScienceResearch #Instrument #NucleicAcidExtraction #PCR #ProteinSynthesis
-
-
Excited to share that we will be at ADLM 2024 in Chicago! Looking forward to discussing our latest Molecular Diagnostics innovations. Visit Bioneer at Booth 4439 and stop by our poster presentations (B-201, B-207) on July 31. #ClinicalEvaluation #RespiratoryViruses #MolecularDiagnostics #POCT #IRONqPCR #ExiStation
Founder, CEO & Chairman, Bioneer Group | CEO at Bioneer | CEO at siRNAgen Therapeutics | CEO at RNApharm
Our team will be at ADLM 2024 in Chicago, Illinois from July 28 – Aug. 1. Visit Bioneer at Booth #4439 to explore our Molecular Diagnostics solutions and discuss insights for future advancements. Don't miss BIONEER poster presentations on July 31: * B-201: Clinical Performance Evaluation of IRON-qPCR™ RV, a Novel Molecular POCT System, for the Qualitative Detection of Respiratory Viruses in Nasopharyngeal Swab * B-207: Clinical Evaluation of ExiStation™ FA 96 RV for the Detection of Human Respiratory Viruses in Human Nasopharyngeal Swab Specimen For more information, visit: https://lnkd.in/geUcMhr7 https://lnkd.in/gH4qrRkU #MolecularDiagnostics #ADLM #ClinicalEvaluation #RespiratoryViruses #POCT
-